SMAD3 and renal fibrosis: Another example is ErbB4-immunoreactivity (Erbb4-IR), which is a novel lncRNA that contributes to TGF-β/Smad3-mediated renal fibrosis and a potential therapeutic target for chronic fibrotic kidney disease [22].